SCHEMBL7987771

SCHEMBL7987771

CCCCOc1ccc(-c2nc(O)c3c(ncn3Cc3ccccc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4E B2RXH2 5/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 1/20 0.41
HPGD P15428 3/20 0.40
MAPT P10636 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GAA P10253 2/20 0.40
RARB P10826 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
ATP4A P20648 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974478 0.91 LMNA (0.43) SMN1; SMN2LMNATSHRHTTNPSR1
SCHEMBL7985395 0.90 GAA (0.43) SMN1; SMN2LMNATSHRHTTNPSR1
SCHEMBL7985225 0.88 GAA (0.48) SMN1; SMN2HTTNPSR1NPC1RAB9A
SCHEMBL7984454 0.86 GAA (0.42) TSHRGAA
SCHEMBL7975267 0.85 SMN1; SMN2 (0.46) SMN1; SMN2LMNATSHRALDH1A1HPGD
SCHEMBL7988558 0.84 SMN1; SMN2 (0.43) SMN1; SMN2TSHRALDH1A1HPGDMEN1
SCHEMBL7985705 0.84 CYP11B1 (0.49) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1
SCHEMBL7984459 0.83 NR1H2 (0.43) SMN1; SMN2LMNAHTTALDH1A1HPGD
SCHEMBL7975133 0.83 ADORA2A (0.50) SMN1; SMN2TSHRALDH1A1HPGDMAPT
SCHEMBL7985071 0.83 BCL2L2 (0.39) SMN1; SMN2LMNAALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed